Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Colorcon
Chinese Patent Office
Baxter
Mallinckrodt
Dow
Covington
Chubb
Johnson and Johnson

Generated: April 23, 2018

DrugPatentWatch Database Preview

ADENOSINE Drug Profile

« Back to Dashboard

When do Adenosine patents expire, and what generic alternatives are available?

Adenosine is a drug marketed by Akorn, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Hospira Inc, and Mylan Asi. and is included in twenty NDAs.

The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the adenosine profile page.
Drug patent expirations by year for ADENOSINE
Pharmacology for ADENOSINE
Medical Subject Heading (MeSH) Categories for ADENOSINE
Synonyms for ADENOSINE
.beta.-Adenosine
.beta.-D-Adenosine
.beta.-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-
.beta.-D-Ribofuranoside, adenine-9
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
[U-14C]adenosine
1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose
1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose
158749-77-0
177030-94-3
1dgm
1odi
244769-76-4
2fqy
2gl0
2ydo
30143-02-3
3axz
3ay0
3H-adenosine
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside
46946-45-6
46969-16-8
4cki
4ckj
4pd9
5536-17-4
58-61-7
6-Amino-9-.beta.-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-Amino-9.beta.-D-ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-delta-ribofuranosyl-9H-purine
9- -D-Ribofuranosyladenine
9-?-D-Ribofuranosyl-9H-purin-6-amine
9-.alpha.-D-Arabinofuranosyladenine
9-.beta.-D-Ribofuranosidoadenine
9-.beta.-D-Ribofuranosyl-9H-purin-6-amine
9-.beta.-d-Ribofuranosyladenine
9-(beta-D-Arabinofuranosyl)adenine
9-beta-D-Ribofuranosidoadenine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyladenine
9beta-D-ribofuranosyl-9H-Purin-6-amine
9beta-D-Ribofuranosyladenine
9beta-delta-ribofuranosyl-9H-Purin-6-amine
9beta-delta-Ribofuranosyladenine
9H-Purin-6-amine, 9-.beta.-d-ribofuranosyl-
9H-Purin-6-amine, 9beta-D-ribofuranosyl-
A0152
AB0012292
AB00384349_13
AB00384349_14
AB00384349-11
AC-27494
AC-8229
AC1L1U8O
AC1Q1ID3
AC1Q52XU
ACT02616
Ade-Rib
Adenin riboside
Adenine 9-beta-D-arabinofuranoside
Adenine nucleoside
Adenine riboside
Adenine riboside, Adenine-9-beta-D-ribofuranoside
Adenine-9- -D-ribofuranoside
Adenine-9-beta-D-ribofuranoside
adenine-9beta-D-Ribofuranoside
adenine-9beta-delta-Ribofuranoside
adenine-D-ribose
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosina
Adenosine (Adenocard)
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine [USAN:USP:BAN]
adenosine-2-13C-N,1,3-15N3
adenosine-8-13C
adenosine-9-15N
adenosine-N-15N
Adenosine, >=99%
Adenosine, European Pharmacopoeia (EP) Reference Standard
Adenosine, homopolymer
Adenosine, pharmaceutical secondary standard; traceable to USP and PhEur
Adenosine, suitable for cell culture, BioReagent
Adenosine, United States Pharmacopeia (USP) Reference Standard
Adenosine, Vetec(TM) reagent grade, 98%
Adenosinum
Adensoine
AI3-52413
AJ-34020
AK-77288
AKOS015888594
alpha-Adenosine
AM83931
ANW-32994
Arabinosyl-adenine
AS-12664
AT-11502
b-D-Adenosine
BB_NC-0565
BDBM14487
beta-Adenosine
beta-D-Adenosine
beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-
beta-D-Ribofuranoside, adenine-9
beta-delta-Adenosine
Bio1_000437
Bio1_000926
Bio1_001415
bmse000061
bmse000996
Boniton
BR-77288
BSPBio_001796
BT000369
C00212
CAS-58-61-7
Caswell No. 010B
CCG-38824
CCRIS 2557
CHEBI:16335
CHEMBL477
cid_191
cid_60961
CJ-07924
CTK1G9587
D-Adenosine
D00045
D06IAR
DB-022408
DB00640
DSSTox_CID_2558
DSSTox_GSID_22558
DSSTox_RID_76628
DTXSID1022558
EA6C60C2-6AFB-4264-A2F0-541373DB950E
EINECS 200-389-9
Epitope ID:140947
Formycin A, from Streptomyces kaniharaensis, >=98% (HPLC)
FT-0082881
FT-0620931
GTPL2844
HMS1920A13
HMS2091G13
HMS2235E24
HSDB 7774
K72T3FS567
KB-47159
KBio3_001296
KS-0000010G
KSC269K8P
LS-15085
MCULE-7071766082
MEDR-640
MFCD00005752
MFCD00065471
MLS000069638
MLS002153227
MLS006010946
MolPort-001-838-229
Myocol
N6-Methylado
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NCGC00178869-03
NSC 627048
NSC 7652
NSC-755857
NSC627048
NSC755857
NSC7652
NU001462
NU007624
NU007625
NU008403
Nucleocardyl
OIRDTQYFTABQOQ-KQYNXXCUSA-N
Pallacor
Pharmakon1600-01500107
Polyadenosine
Polyriboadenosine
PubChem9306
REGID_for_CID_60961
Riboadenosine
RP29522
RP29523
RTR-020367
S-3476
s1647
Sandesin
SBI-0206673.P002
SCHEMBL731
SDCCGMLS-0003108.P003
SMR000058216
SPBio_001194
SPECTRUM1500107
Spectrum2_001257
Spectrum3_000288
SR 96225
SR-05000001981
SR-05000001981-2
SR-96225
ST009496
ST2407911
SUN-Y4001
TL8003749
Tox21_110891
Tox21_110891_1
TR-020367
UNII-K72T3FS567
USAF CB-10
Z1741978458
ZINC2169830

US Patents and Regulatory Information for ADENOSINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn ADENOSINE adenosine INJECTABLE;INJECTION 078076-001 Oct 31, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Emcure Pharms Ltd ADENOSINE adenosine SOLUTION;IV (INFUSION) 202313-001 Sep 15, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Asi ADENOSINE adenosine SOLUTION;IV (INFUSION) 090212-001 Mar 28, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd ADENOSINE adenosine INJECTABLE;INJECTION 078686-001 May 13, 2009 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Boehringer Ingelheim
Express Scripts
Federal Trade Commission
Cerilliant
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.